Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

Featuring perspectives from Dr Adam M Brufsky and Dr Kevin Kalinsky, including the following topics:

Introduction (0:00)
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Therapy for Triple-Negative Breast Cancer (TNBC) — Dr Brufsky (5:08)
Established Treatment Paradigm for Localized and Metastatic TNBC — Dr Kalinsky (35:20)